Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Immuneering Corp’s current trading price is -25.36% away from its 52-week high, while its distance from the 52-week low is 250.00%. The stock’s price range over this period has fluctuated between $1.00 and $4.69. The company, operating within the financial sector, had a trading volume of approximately 0.61 million for the day, which was noticeably lower than the average daily share volume of 1.26 million over the last 3 months.
At present, Immuneering Corp (IMRX) has a stock price of $3.5. In the previous session, the stock saw a rise, peaking at $21.0 after an opening price of $3.5. The day’s lowest price was $8.0, and it closed at $3.76.
Immuneering Corp saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $4.69 on 07/23/25, while the lowest price for the same duration was marked at $1.00 on 08/23/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Immuneering Corp (IMRX) has experienced a quarterly rise of 143.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 125.95M and boasts a workforce of 66 employees.
Immuneering Corp: What Analysts Are Saying
As of right now, 3 analysts are rating Immuneering Corp as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.41, with a change in price of +1.81. Similarly, Immuneering Corp recorded 861,947 in trading volume during the last 100 days, posting a change of +107.10%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IMRX stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.13.
IMRX Stock Stochastic Average
Today, Immuneering Corp’s raw stochastic average for the past 50 days stands at 60.74%, indicating a rise from the raw stochastic average of the last 20 days, which was 33.53%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 29.81% and 20.95% respectively.
IMRX Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 224.07%.However, over the last six months, we can see a weaker performance of 88.17%. Over the last 30 days, the price of IMRX has leaped by -15.25%. And in the last five days, it has surged by 9.03%.
